Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700916 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
A Early Phase 1 study of Obesity and Dyslipidemias, sponsored by University of Connecticut.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT05700916 is a Early Phase 1 study of Obesity and Dyslipidemias that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 130 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05700916, a Early Phase 1 study of Obesity and Dyslipidemias, is actively recruiting participants, sponsored by University of Connecticut.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
Conditions Studied
Interventions
- DRUG Milk Polar Lipid-Rich Dairy Powder
- DIETARY_SUPPLEMENT Dairy Powder
Study Locations (1)
Connecticut
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2023-10-20 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05700916
The ClinicalTrials.gov registry entry for NCT05700916 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Milk Polar Lipid-Rich Dairy Powder is the first listed.
NCT05700916 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05700916 about?
NCT05700916 is a clinical study titled "Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity". The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
What is the current status of trial NCT05700916?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 130 participants. The study started on 2023-10-20. Estimated completion is 2026-06.
What conditions does trial NCT05700916 study?
This clinical trial studies the following conditions: Obesity, Dyslipidemias.
What interventions are being tested in trial NCT05700916?
The interventions under investigation include: Milk Polar Lipid-Rich Dairy Powder (DRUG), Dairy Powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05700916?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05700916 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation
RECRUITING · Early Phase 1
-
Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
RECRUITING · Early Phase 1
-
Social Determinants of Sleep and Obesity
RECRUITING · Early Phase 1
-
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
RECRUITING · Early Phase 1
-
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
RECRUITING · Early Phase 1
-
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.